Main Category: Stem Cell Research
Also Included In: Genetics
Article Date: 27 Sep 2013 – 0:00 PDT
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
‘This is a huge milestone for King’s, and will allow us to make a major contribution to global stem cell research by having these stem cell lines available to scientists in the USA.
If you write about specific medications or operations, please do not name health care professionals by name.
MLA
‘These research-grade stem cell lines are essential not only to address basic questions in development and disease, but to test and implement technical improvements in culture conditions that might affect hES cell viability and pluripotency.’
Professor Peter Braude, Emeritus Professor of Obstetrics and Gynaecology, King’s College London; and former director of the Stem Cell Programme and the Pre-Implantation Genetic Diagnosis Programme, Guy’s and St Thomas’ NHS Foundation Trust, said: ‘We are delighted that the NIH has found our lines useful and their procurement and consents in line with the strict guidelines that they have set. This achievement is the culmination of over ten years of painstaking research and consistent belief in the scientific usefulness of these very special cells to improve our understanding of genetic disease processes.
Current ratings for:
Disease-specific human embryonic stem cell lines placed on NIH Stem Cell Registry
Scientists from King’s College London have announced that 16 human embryonic stem (hES) cell lines have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. The stem cell lines, which carry genes for a variety of hereditary disorders such as Huntington’s disease, spinal muscular dystrophy and cystic fibrosis, are considered to be ideal research tools for designing models to understand disease progression, and ultimately in helping scientists develop new treatments for patients.
Please note: If no author information is provided, the source is cited instead.
All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.
London, King\’s College. “Disease-specific human embryonic stem cell lines placed on NIH Stem Cell Registry.” Medical News Today. MediLexicon, Intl., 27 Sep. 2013. Web.
27 Sep. 2013. <http://www.medicalnewstoday.com/releases/266612.php>
stem cell research section for the latest news on this subject.